A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic …

S Dunne, B Shannon, C Dunne, W Cullen - BMC Pharmacology and …, 2013 - Springer
Generic medicines are those where patent protection has expired, and which may be
produced by manufacturers other than the innovator company. Use of generic medicines …

The impact of patent expiry on drug prices: a systematic literature review

GT Vondeling, Q Cao, MJ Postma… - … health economics and …, 2018 - Springer
Objective The aim of this study was to evaluate the impact of patent expiry on drug prices by
means of a systematic literature review. Methods A systematic literature search was …

Pharmaceutical industry–sponsored meals and physician prescribing patterns for Medicare beneficiaries

C DeJong, T Aguilar, CW Tseng, GA Lin… - JAMA internal …, 2016 - jamanetwork.com
Importance The association between industry payments to physicians and prescribing rates
of the brand-name medications that are being promoted is controversial. In the United …

[BOOK][B] Soft innovation: economics, product aesthetics, and the creative industries

P Stoneman - 2010 - books.google.com
At its heart this book is about innovation and the innovation process. On the way, it considers
aesthetics, design, creativity and the creative industries, and a number of other similar …

Comparing generic drug markets in Europe and the United States: prices, volumes, and spending

OJ Wouters, PG Kanavos, M McKee - The Milbank Quarterly, 2017 - Wiley Online Library
Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …

Innovation in the pharmaceutical industry: The process of drug discovery and development

E Petrova - Innovation and Marketing in the Pharmaceutical …, 2013 - Springer
Continuous innovation is one of the pharmaceutical industry's most defining characteristics.
New medications can be crucial for maintaining the quality of human life, and may even …

The effect of country of origin on brand equity: an empirical study on generic drugs

S Nath Sanyal, SK Datta - Journal of Product & Brand Management, 2011 - emerald.com
Purpose–The purpose of this paper is to explore the impact of country of origin image on
brand equity of branded generic drugs. Design/methodology/approach–Brand equity of …

Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000–2010

WA Kaplan, LS Ritz, M Vitello, VJ Wirtz - Health policy, 2012 - Elsevier
OBJECTIVE: Review the literature on the impact of policies designed to enhance uptake of
generic medicines in low and middle income countries (LMICs). METHODS: We searched …

Reforms in the Greek pharmaceutical market during the financial crisis

S Vandoros, T Stargardt - Health policy, 2013 - Elsevier
INTRODUCTION: Following the financial crisis of 2008, Greece has been facing severe
fiscal problems associated with high public debt and deficit. Given their significant …

Definition and classification of generic drugs across the world

R Alfonso-Cristancho, T Andia, T Barbosa… - … health economics and …, 2015 - Springer
Our aim was to systematically identify and compare how generic medications, as defined by
the US Food and Drug Administration (FDA), World Health Organization (WHO), and …